Manuel Ortega

Manuel Ortega is a seasoned professional in the pharmaceutical industry, currently serving as General Manager at Idorsia Pharmaceuticals Ltd since September 2021. Previously, Manuel held the position of General Manager for Spain and Portugal at Arvelle Therapeutics for a brief period in 2020, and managed the Iberian Cluster at Theramex from 2018 to 2020. Experience includes senior roles at BIOTRONIK, where Manuel was Senior VP of Product Management, Marketing, and Market Access, and at Merck Group as Regional Franchise Head for Neurodegenerative Diseases in Latin America, overseeing business strategy across multiple countries. Earlier roles at Merck included VP of Global Marketing for the Fertility Franchise and various leadership positions in the Iberian region. Manuel began a career in the pharmaceutical sector at Aventis and Rhone-Poulenc Rorer, focusing on neurology and other therapeutic areas, and has a foundational background in clinical research from Serono Pharma. Manuel Ortega holds a degree in Veterinary Sciences from Universidad Complutense de Madrid.